The market model places Biosense Webster, Abbott and Medtronic as market leaders. "Kardium’s pulsed field ablation clinical trial enters final stages" was originally created and published by ...

Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes.

Abbott has been investing in structural heart products and recently entered the fast-growing left atrial appendage closure market. Despite falling behind in the race for pulsed field ablation ...

With the introduction of pulsed-field ablation, patients can have a non-thermal form of ablation. This technology delivers pulsed electrical fields through an ablation catheter to selectively ...

The Clarivate e-book highlights new medtech breakthroughs in the pulsed field ablation (PFA) market, forecasting its future growth and showcasing the technology's potential to transform the ...

Bernstein analyst Lee Hambright lowered the firm’s price target on Abbott (ABT ... that include robotic-assisted surgery, pulsed field ablation, insulin pumps, and new AI-enabled functionality ...

Steven Mickelsen, the electrophysiologist who founded Farapulse before it was sold to Boston Scientific in 2021, is taking pulsed field ablation into new territory with the development of a device ...

After more than a monthlong pause in response to four neurovascular events linked to its Varipulse pulsed-field ablation system, Johnson & Johnson announced late last week that it will resume use of ...